Crynodeb
The invention provides a DNA molecule comprising a promoter sequence operably linked to a DNA sequence encoding first and second proteins linked by a hinge region wherein in that the promoter sequence can be one having activity which is induced in response to a change in the surrounding environment and the first protein can be Tetanus toxin C fragment or one or more epitopes thereof. The invention also provides intermediate molecules having a promoter operably linked to a DNA sequence encoding a first antigenic sequence and a hinge region, and at or adjacent the 3′-end thereof one or more restriction sites for the introduction of a second anti-genic sequence. In addition, the invention provides replicable expression vectors containing the DNA fusion proteins expressed therefrom, bacterial transformed with the vectors and the use of the bacteria, in vaccines.
| Iaith wreiddiol | Saesneg |
|---|---|
| Rhif y patent | WO1994003615A1 |
| Dyddiad blaenoriaeth | 31 Gorff 1992 |
| Dyddiad ffeilio | 30 Gorff 1993 |
| Statws | Cyhoeddwyd - 17 Chwef 1994 |
NDC y CU
Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol
-
NDC 3 Iechyd a Llesiant Da
Ôl bys
Gweld gwybodaeth am bynciau ymchwil 'Expression of recombinant fusion proteins in attenuated bacteria'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.Dyfynnu hyn
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver